Purchase Order 75F40123P00442
- Not listed
- This is a $541,578 firm fixed price purchase order issued by the Department of Health and Human Services Food and Drug Administration (FDA) to the Texas Biomedical Research Institute, doing business as the Southwest Foundation For Biomedical Research. The contract is for the delivery of Bordetella-free weanling baboons to support the FDA's Center for Biologics Evaluation and Research (CBER) research on pertussis disease and vaccines. The contract has no set-aside designation. The Texas...
- This federal contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the Texas Biomedical Research Institute, doing business as the Southwest Foundation For Biomedical Research. The $283,594.70 firm fixed price purchase order is for the delivery of bordetella-free weanling baboons. The contract does not have a set-aside designation. Texas Biomedical Research Institute is an independent, non-profit research organization focused on infectious...
- This federal contract award was made by the Food and Drug Administration (FDA) to the Texas Biomedical Research Institute, doing business as the Southwest Foundation For Biomedical Research, for the provision of weanling baboons. The contract is a Firm Fixed Price Purchase Order with a ceiling value of $90,000.00 and an ultimate completion date of March 23, 2016. The contract was awarded on August 28, 2015 without any set-aside designation. The Texas Biomedical Research Institute is a leading...
- This is a $256,619.89 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to the Texas Biomedical Research Institute, doing business as the Southwest Foundation For Biomedical Research. The contract is for the provision of Bordetella-free weanling baboons. The award does not have a set-aside designation. The Texas Biomedical Research Institute is a leading independent biomedical research organization that specializes in infectious disease research, particularly...
- This federal contract award, valued at $179,084.58, was issued by the Food and Drug Administration (FDA) to the Texas Biomedical Research Institute, doing business as the Southwest Foundation For Biomedical Research. The contract is for the supply of Bordetella-free weanling baboons, which will be used for research purposes. The Texas Biomedical Research Institute is a leading independent biomedical research organization that specializes in infectious disease research, particularly focusing on...
- This $75,061 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Texas Biomedical Research Institute, doing business as the Southwest Foundation for Biomedical Research. The contract is for the provision of Bordetella-free weanling baboons. The contract was awarded on June 19, 2019 and has an ultimate completion date of October 17, 2019. The contract was not set aside and was awarded under a solicitation posted on May 16, 2019. The Texas Biomedical...
- The Food and Drug Administration awarded a $911.7K firm fixed-price purchase order to The University of Texas MD Anderson Cancer Center in Houston, Texas on August 17, 2020, to conduct a five-year study evaluating the duration of pertussis immunity in baboons. Under this contract, MD Anderson will house and maintain up to 36 baboons (24 vaccinated and 12 convalescent) and collect biological samples while administering vaccines according to the statement of work requirements. The FDA's evaluation...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $237,920.72 firm fixed price purchase order to Texas Biomedical Research Institute (also doing business as Southwest Foundation for Biomedical Research) for a baboon study. The contract was awarded on September 15, 2022, with an ultimate completion date of September 14, 2023, and performance will be conducted at the awardee's facility in San Antonio, Texas. No set-aside designation was applied to this award. Texas...
- This is a firm fixed price purchase order issued by the Department of Health and Human Services Food and Drug Administration (FDA) to The University of Texas MD Anderson Cancer Center (MD Anderson), a component of the University of Texas System, to provide 24 age-matched, Bordetella-free weanling baboons for use in Pertussis infection and vaccination studies. The contract has a potential value of $187,360.62 and was awarded on April 19, 2019 under full and open competition, with no set-aside...
- This is a $4,722,966.14 firm fixed-price definitive contract awarded by the Joint PEO Chemical and Biological Defense to the Texas Biomedical Research Institute, doing business as the Southwest Foundation For Biomedical Research. The contract, which does not have a set-aside designation, supports the development and refinement of animal and animal replacement models for evaluating candidate countermeasures against infectious agents with pandemic potential. The institute operates the Southwest...
The Department of Health and Human Services Food and Drug Administration awarded a $193,026 firm fixed price purchase order to Texas Biomedical Research Institute, doing business as Southwest Foundation For Biomedical Research. The purpose of this contract is to obtain baboons for an OMV-pertussis vaccine study to be conducted at the FDA/CBER facility in Silver Spring, Maryland. Performance will take place in San Antonio, Texas over a one year period concluding in late September 2024. No subcontractors or set aside designations were indicated. This award will support vaccine research and development efforts at the FDA's Center for Biologics Evaluation and Research facility as they work to advance pertussis vaccine technology and public health goals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $193.0k | 9/27/23 |